Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Lung
100%
Ex Vivo
46%
Molecular Imaging
36%
Endomicroscopy
33%
Neutrophil
18%
Polypeptide Antibiotic Agent
16%
Randomized Controlled Trial
13%
COVID-19
13%
Leukocyte Activation
13%
Endoscope
13%
Confocal Laser Scanning Microscopy
13%
Health Care Cost
13%
Imaging Agent
13%
Galectin 3
13%
Imaging Technique
13%
Gram-Negative Bacteria
13%
Gram-Positive Bacteria
13%
Thrombopoietin
13%
Microendoscopy
13%
Circadian Rhythm
13%
Megakaryocyte
13%
Lipid A
13%
Gene Expression
13%
Platelet
13%
Lung Enzyme
13%
Enzyme Activity
13%
In Vitro
11%
Fluorescence Microscopy
10%
Matrix Metalloproteinase
9%
Food Intake
8%
Optical Imaging
7%
Silo-Filler's Disease
7%
Bacterium Detection
6%
Autofluorescence
6%
Light Dark Cycle
6%
Focused Ion Beam
6%
Pseudomonas aeruginosa
5%
Cystic Fibrosis
5%
Amino Acid
5%
Lung Lavage
5%
Immunology and Microbiology
Neutrophil
64%
Peptides
52%
Antimicrobial Peptides
42%
In Vitro
27%
Bacterium Detection
26%
Formyl Peptide Receptor 1
26%
Molecular Imaging
25%
Leukocyte Activation
14%
Fluorescence Microscopy
13%
Microorganism Detection
13%
Pseudomonas aeruginosa
13%
Gram-Negative Bacteria
13%
Infection
13%
Aspergillus fumigatus
10%
Protein Secondary Structure
10%
Macrophage
10%
Bronchoalveolar Lavage Fluid
9%
Infectious Agent
8%
Escherichia coli
8%
Solution and Solubility
6%
Peptide Stability
6%
Autofluorescence
6%
Chemical Structure
6%
Bacterial Membrane
6%
Colony-Forming Unit
6%
Decision Making
6%
Mononuclear Cell
6%
Klebsiella pneumoniae
6%
Methicillin Susceptible Staphylococcus Aureus
6%
Pulmonary Inflammation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Polypeptide Antibiotic Agent
26%
Acute Lung Injury
26%
Randomized Controlled Trial
26%
Antiinfective Agent
21%
Cystic Fibrosis
13%
Brain Concussion
13%
Formylpeptide Receptor
13%
Thrombopoietin
13%
Nafamstat
13%
Nafamstat Mesilate
13%
Lung Enzyme
13%
Matrix Metalloproteinase
13%
Galectin 3
13%
Eugenol
13%
Amino Acid
13%
Traumatic Brain Injury
13%
Lipopolysaccharide
13%
Pharmacokinetics
13%
Pharmacodynamics
13%
Klebsiella pneumoniae
10%
Focused Ion Beam
8%
Fluorescence Microscopy
8%
Nanocapsule
8%
Escherichia coli
8%
Adverse Event
7%
Pseudomonas aeruginosa
6%
Methicillin Susceptible Staphylococcus Aureus
6%
Peptide Stability
6%
Lung Infection
6%
Clinical Trial
6%
Inflammation
5%
Adult Respiratory Distress Syndrome
5%